Restless legs syndrome. Polyneuropathy in diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Co-occurrence of multiple sclerosis and restless legs syndrome
Exclusion criteria
Exclusion criteria: Having any chronic neurological, psychological, or metabolic disease Pregnancy or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of restless legs syndrome. Timepoint: At the beginning of the study and 4 weeks later. Method of measurement: Restless Legs Syndrome Rating Scale (RLSRS) questionnaire.;Sleep quality. Timepoint: At the beginning of the study and 4 weeks later. Method of measurement: Pittsburgh Sleep Quality Index (PSQI) questionnaire.;Quality of life. Timepoint: At the beginning of the study and 4 weeks later. Method of measurement: Multiple Sclerosis Quality of Life (MSQOL-54) questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Any possible side effects. Timepoint: During the use of herbal medicine. Method of measurement: Questioning the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Kerman University of Medical Sciences